METHODS AND KITS FOR DETERMINING DRUG SENSITIVITY IN PATIENTS INFECTED WITH HCV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100183555A1
SERIAL NO

12525944

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An in vitro method for determining whether a patient infected with HCV is a responder or non-responder to the treatment with interferon-alpha and ribavirin. More specifically, the method includes a step of determining the expression level of the IFI27, CXCL9 and G1P2 genes in a biological sample.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITE RENE DESCARTES (PARIS V)F-75006 PARIS
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS3 AVENUE VICTORIA 75004 PARIS FRANCE
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE PARIS 7 - DENIS DIDEROTF-75005 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Asselah, Tarik Paris, FR 8 39
Bieche, Ivan Suresnes, FR 8 33
Marcellin, Patrick Paris, FR 8 42
Vidaud, Michel Fontenay Sous Bois, FR 9 36

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation